Phages are harnessing the power of small RNA to take control of bacterial cells and enhance their own replication process. As antibiotic-resistant infections continue to escalate, posing a dire threat to global health—projected to claim as many as 10 million lives annually by 2050—scientists are turning their attention to bacteriophages, which are viruses that specifically target bacteria, as a potential solution. A recent study sheds light on how these phages utilize a minuscule RNA molecule known as PreS to commandeer bacterial cells, significantly increasing their replication efficiency. This discovery offers valuable insights that could pave the way for the development of more effective phage-based therapies.
Conducted at the Hebrew University of Jerusalem, this groundbreaking research reveals the intricate mechanisms by which bacteriophages, often referred to simply as phages, employ a tiny strand of genetic material to invade bacterial cells and produce more viral copies. The study uncovers that PreS operates as an internal "switch" within the bacterial cell. When activated, this switch alters the cellular functions of the bacterium, propelling the infection forward.
Antibiotic resistance has emerged as one of the most significant public health challenges of our time. Current estimates suggest that by 2050, infections stemming from bacteria resistant to antibiotics could result in up to 10 million deaths each year around the globe. Amidst this looming crisis, phage therapy is gaining momentum as a viable alternative, utilizing viruses that exclusively target bacteria rather than relying solely on traditional antibiotics.
By understanding how phages like those studied leverage tools such as PreS to seize control of bacterial cells, researchers can glean essential knowledge that may lead to the creation of smarter and more effective phage treatments in the future.
The research team, led by Dr. Sahar Melamed and including PhD student Aviezer Silverman, MSc student Raneem Nashef, and computational biologist Reut Wasserman, alongside Prof. Ido Golding from the University of Illinois Urbana-Champaign, found that the phage synthesizes a small RNA called PreS that functions as a molecular switch.
Previous research on phages has largely concentrated on viral proteins, but this study highlights the significant role that RNA molecules play in swiftly reprogramming the host cell, even after bacterial genes have been transcribed into messenger RNA (mRNA). This additional layer of control enhances the infection process.
PreS binds to crucial bacterial mRNA and modifies it in a manner that facilitates the virus's ability to replicate its DNA and efficiently advance toward the stage where new virus particles are produced, ultimately leading to the lysis of the bacterial cell. Using advanced techniques known as RIL-seq to map RNA-RNA interactions, the researchers identified that PreS targets a specific bacterial message responsible for producing DnaN, a protein essential for DNA replication. By promoting the synthesis of DnaN, PreS gives the virus a significant advantage as the infection progresses.
Interestingly, PreS alters the structure of the bacterial dnaN message. Typically, this mRNA is tightly folded, which hampers access for the ribosomes—the cellular machinery responsible for protein synthesis. PreS attaches to the folded region, unwinding it and enabling ribosomes to read and translate the message more effectively.
The outcome of this interaction leads to an increase in DnaN protein levels, accelerating viral DNA replication and intensifying the infection. The researchers observed that when PreS was removed or its binding site was disrupted, the phage exhibited reduced virulence, slower replication rates, and delayed onset of its destructive phase.
This finding is particularly noteworthy because small RNAs have not historically been recognized as significant players in phage biology. However, the conservation of PreS across many related viruses suggests that phages may possess a shared toolkit of small RNAs, which scientists are just beginning to explore.
Dr. Sahar Melamed commented on the implications of this research, stating, "This small RNA provides the phage with an additional layer of control. By regulating vital bacterial genes at precise moments, the virus enhances its likelihood of successful replication. What surprised us the most is that phage lambda, one of the most extensively studied viruses for over 75 years, still conceals secrets. Discovering an unexpected RNA regulator in such a well-known system indicates that we have only scratched the surface of what may be a vastly richer, more complex landscape of RNA-mediated controls in phages."
Looking to the future, comprehending how phages manipulate bacterial cells is essential for advancing both fundamental scientific knowledge and practical medical applications. As the search for solutions to combat antibiotic-resistant infections intensifies, phages are increasingly being recognized as a targeted and adaptable form of therapy.
Discoveries like PreS exemplify how even the tiniest viral components can have a profound impact on the success of an infection. In the long run, this understanding may enable researchers to engineer phages that are not only safer but also more reliable and potent in the ongoing battle against drug-resistant bacteria.
